77 search results for lung cancer

NCCN_Oncology_Research_Program_Brochure

of patients with suspected or newly diagnosed lung cancer in Antelope Valley, one of the most underserved regions of Southern California. Antelope Valley has the highest rate of lung cancer mortality, of the first lung cancer screening program in Antelope Valley. This initiative has touched many, and treatment of lung cancer in this underserved area.” Dan J. Raz, MD City of Hope National Medical Center, that improve the lives of patients with cancer. National Comprehensive Cancer Network® Namrata Vijayvergia

News

Lung Cancer in High-Risk Patients (Case Comprehensive Cancer Center/University Hospitals Seidman Cancer, with Cancer Should Consider Participating in Clinical Trials. Learn more. Patient Advocates from NCCN Guidelines Panels Share Their ‘United by Unique’ Stories for World Cancer Day. Learn more, Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient, , equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical

AC2024 Exhibit Guide

, and thoracic cancers, which includes lung cancer. Driven by science, we are committed, Association ............ A1 GO2 for Lung Cancer .............................. A16 Head and Neck, transformative therapies in some of the world’s most common cancers, including breast cancer, e s t h a t w e s e e k t o s e r ve. Eisai is proud to support the National Comprehensive Cancer, the growth of cancers such as multiple myeloma. Everything we do gets us closer to a future where

NCCN_ExhibitHall_Floorplan_2024

Crossroads4Hope ............................... A9 Global Colon Cancer Association ...... A1 GO2 for Lung Cancer ........................ A16 Head and Neck Cancer Alliance......... A4 Imerman Angels, ....................................... 724 Moffitt Cancer Center ....................... 623 Roswell Park Comprehensive Cancer Center ................................... 625 REIMBURSEMENT RESOURCE ROOM Astellas, of Cancer Care Centers (ACCC) ................................. A14 Bladder Cancer Advocacy

Framework for Resource Stratification

3.2025 Non-Small Cell Lung Cancer Basic Resources Version 4.2024 Core, . The NCCN Framework™ outlines a rational approach for building cancer management systems to provide the highest achievable cancer care by applying available and affordable services in a logical, to the allocation of resources, providing a structure for improving cancer care. Treatment recommendations, available resources should be provided. If Basic Resources for cancer treatment are unavailable

Guidelines With Evidence Blocks

Cancers Version 3.2024 Cervical Cancer Version 4.2024 Chronic Lymphocytic Leukemia, Esophageal and Esophagogastric Junction Cancers Version 5.2024 Gastric Cancer Version 4.2024, Version 2.2024 Non-Small Cell Lung Cancer Version 11.2024 Occult Primary, Adenocarcinoma Version 1.2025 Small Cell Lung Cancer Version 3.2025 Soft Tissue Sarcoma, AND DEFINITIONS © National Comprehensive Cancer Network® The goal is to provide the health care provider

NCCN SOSF 2024 Thirteenth Annual Summary

, NCCN Panelists included: • Arun Krishna, PhD, Vice-President, US Franchise Head & Lung Cancer, featured on the panel. Dr. Krishna discussed the importance of lung cancer screening because the U.S., of 2023 entitled Cancer Across Geography which resulted in a subsequent JNCCN publication. Many of our, the Reducing Hereditary Cancer Act, among a variety of other federal pieces of legislation. NCCN, Guidelines® into law when appropriate, fertility preservation, access to hereditary cancer screening

Detection, Prevention, and Risk Reduction

Lung Cancer Screening Version: 1.2025 Prostate Cancer Early Detection Version: 2.2024, ®) are posted with the latest update date and version number. Breast Cancer Risk Reduction Version: 2.2025 Breast Cancer, Colorectal Cancer Screening Version: 1.2024

Member Institution Toolkit

for Patients Free Patient Webinar: Small Cell Lung Cancer Not a CE-certified activity, Lung Cancer Earn CE credit. EVENT DETAILS May 31-June 2, 2025, collective mission to define and advance quality, effective, equitable, and accessible cancer care, in Oncology (NCCN Guidelines®) Collaborate with other leading academic cancer centers and utilize NCCN, Resources | Patient Resources | Research Opportunities | Advancing Cancer Equity | CE

2021_Elevating_Cancer_Equity_Webinar_Slides

2021_Elevating_Cancer_Equity_Webinar_Slides,
                        Prostate Cancer Lung Cancer 13 © National Comprehensive Cancer Network, Inc. 2021, All Rights, Prevalence Va r i e s G e o g raphically 2017 Medicare Population 25 Lung Cancer Prostate Cancer,  1 © National Comprehensive Cancer Network, Inc. 2021, All Rights Reserved. No part, or mechanical, without first obtaining written permission from NCCN ® . Elevating Cancer Equity: Recommendations to Reduce Racial Disparities in Guideline Adherent Cancer Care February 22, 2021

NCCN Guidance on Inclusive Language

(eg, a person with lung cancer rather than a lung cancer patient ). An illness or disease, , 2022. IASLC Language Guide. International Association for the Study of Lung Cancer; 2021. Available, Version 1.0 | April 4, 2023 © 2023 National Comprehensive Cancer Network® (NCCN®) NCCN: Language Guidance Version 1.0 April 4, 2023 Page 1 of 8 © 2023 National Comprehensive Cancer Network, the goals of equity, inclusion, and representation in cancer care. These measures have been approached

Calendar of Events

April 21, 2025 Live Webinar for Patients Free Patient Webinar: Small Cell Lung Cancer, Register Now! NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium Earn CE and MOC credit. | In-person and virtual attendance available, Webinar: Why Should I Consider a Clinical Trial? Join trusted experts to learn about cancer, Fellows Program: New Horizons in Quality Cancer Care™ Designed to meet the educational needs

Submission Request History

/Rectal Cancers Submitted by Colorectal Cancer Alliance on 07/08/2022 ctDNA testing for Colon/Rectal Cancers Submitted by Fight Colorectal Cancer on 07/18/2022 ctDNA for Rectal Cancer, ctDNA testing for Colon/Rectal Cancers Submitted by Colon Cancer Coalition on 07/25/2022, testing for Colon/Rectal Cancers Submitted by Invitae on 08/01/2022 CGP for Colon Cancer, Cancers Submitted by Colorectal Cancer Alliance on 08/04/2023 Avelumab for Colon/Rectal Cancers

Employer Toolkit

Guidelines; NCCN Guidelines for Patients: Lung Cancer Screening; NCCN Guidelines for Detection, Quality Cancer Care In order to promote and support the highest quality of cancer care for plan members, , including definitions and references Strategies and Tactics for Delivering High Quality Cancer Care, cancer care, and they may be addressed in any order to appropriately serve the needs of each, professional societies and regulatory agencies, such as the NCCN Guidelines for Treatment by Cancer Type

Ways to Give

interested in giving toward specific areas of cancer (i.e. breast cancer, lung cancer, etc.) should, Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation, and for adaptation of new Guidelines for additional cancer topics. Specific NCCN Guidelines, top next-generation cancer researchers, guiding the course of treatment innovation and advancement

RRR PDF 2021

for clinicians and others who work with patients with cancer. A s a response to these ongoing challenges, help, search by cancer type or supportive care indication, drug name, or by reimbursement or assistance, and services at: NCCN.org/reimbursement Reimbursement Resource Guide National Comprehensive Cancer Network® National Comprehensive Cancer Network® Reimbursement Resource Guide NCCN.org/reimbursement, cancer patients. Practices and patients are assigned a dedicated Oncology Nurse Advocate who will seek

NCCN Annual Report